Octapharma USA, Inc., a prominent player in the biopharmaceutical industry, is headquartered in the United States, with significant operations across North America. Founded in 1983, Octapharma has established itself as a leader in the development and production of human proteins derived from human plasma and recombinant technologies. The company’s core offerings include a range of therapeutic products for treating conditions such as bleeding disorders, immune deficiencies, and critical care needs. What sets Octapharma apart is its commitment to high-quality, innovative therapies that enhance patient outcomes. With a strong market position, Octapharma has achieved notable milestones, including extensive research and development initiatives that underscore its dedication to advancing healthcare solutions. As a trusted name in the biopharmaceutical sector, Octapharma continues to make significant contributions to patient care and treatment advancements.
We don't have data for Octapharma USA, Inc., but we can show you information about their parent organization instead.
View parent company